Endo International

Go or no go? Pandemic looms over FDA timelines

Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.

Mylan gets an injection, administered by Pfizer

The combination of Upjohn and Mylan means that, for a change, Pfizer is getting smaller. But will the company’s new chief executive really be able to resist the urge to merge?

May 14, 2019

Price fixing case caps a terrible week for generics

Shares in generics firms tumble in the wake of a huge lawsuit in the US alleging industry-wide price fixing, signalling many more years of pain for this sector.

April 17, 2018

Private equity cleans up Sanofi’s failed generics foray

February 15, 2018

Vantage view – Doing what's possible on drug prices

June 14, 2017

Therapy focus – Pain pipeline comes under pressure

June 09, 2017

FDA’s move could mean Endo suffers from opioid withdrawal

April 27, 2017

Interview – Kempharm feels the pain

April 25, 2017

Fresenius shows biotech how to get the deals done

March 21, 2017

Nektar reaches the Summit

March 17, 2017

Snippet roundup: Medica and Cell Medica are in the money, but Endo and Valeant feel the pain

Load More